Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
1.
Biomedical and Environmental Sciences ; (12): 3-18, 2024.
Article in English | WPRIM | ID: wpr-1007904

ABSTRACT

OBJECTIVE@#This study aimed to investigate the potential relationship between urinary metals copper (Cu), arsenic (As), strontium (Sr), barium (Ba), iron (Fe), lead (Pb) and manganese (Mn) and grip strength.@*METHODS@#We used linear regression models, quantile g-computation and Bayesian kernel machine regression (BKMR) to assess the relationship between metals and grip strength.@*RESULTS@#In the multimetal linear regression, Cu (β = -2.119), As (β = -1.318), Sr (β = -2.480), Ba (β = 0.781), Fe (β = 1.130) and Mn (β = -0.404) were significantly correlated with grip strength ( P < 0.05). The results of the quantile g-computation showed that the risk of occurrence of grip strength reduction was -1.007 (95% confidence interval: -1.362, -0.652; P < 0.001) when each quartile of the mixture of the seven metals was increased. Bayesian kernel function regression model analysis showed that mixtures of the seven metals had a negative overall effect on grip strength, with Cu, As and Sr being negatively associated with grip strength levels. In the total population, potential interactions were observed between As and Mn and between Cu and Mn ( P interactions of 0.003 and 0.018, respectively).@*CONCLUSION@#In summary, this study suggests that combined exposure to metal mixtures is negatively associated with grip strength. Cu, Sr and As were negatively correlated with grip strength levels, and there were potential interactions between As and Mn and between Cu and Mn.


Subject(s)
Cross-Sectional Studies , Bayes Theorem , China/epidemiology , Metals/toxicity , Arsenic , Strontium
2.
Journal of Peking University(Health Sciences) ; (6): 44-51, 2023.
Article in Chinese | WPRIM | ID: wpr-971272

ABSTRACT

OBJECTIVE@#To investigate the preparation of decellularized small intestinal submucosa (dSIS) sponge scaffolds with chelated strontium (Sr) ions at different pH values, and to select the appropriate pH values for synthesizing Sr/dSIS scaffolds using the physicochemical properties and biocompatibility of the scaffolds as evaluation indexes.@*METHODS@#(1) Sr/dSIS scaffolds preparation and grouping: After mixing dSIS solution and strontium chloride solution in equal volumes, adjusting pH of the solution to 3, 5, 7, and 9 respectively, porous scaffolds were prepared by freeze-drying method after full reaction at 37℃, which were named Sr/dSIS-3, -5, -7, and -9 respectively, and the dSIS scaffolds were used as the control group. (2) Physicochemical property evaluation: The bulk morphology of the scaffolds was observed in each group, the microscopic morphology analyzed by scanning electron microscopy, and the porosity and pore size determined, the surface elements analyzed by energy spectroscopy, the structure of functional groups analyzed by infrared spectroscopy, the chelation rate determined by atomic spectrophotometry, the water absorption rate detected by using specific gravity method, and the compression strength evaluated by universal mechanical testing machine.(3) Biocompatibility evaluation: The cytotoxicity and proliferative effect to bone mesenchymal stem cells (BMSCs) of each group were evaluated by Calcein-AM/PI double staining method.@*RESULTS@#Scanning electron microscopy showed that the scaffolds of each group had an interconnected three-dimensional porous structure with no statistical difference in pore size and porosity. Energy spectrum analysis showed that strontium could be detected in Sr/dSIS-5, -7 and -9 groups, and strontium was uniformly distributed in the scaffolds. Functional group analysis further supported the formation of chelates in the Sr/dSIS-5, -7 and -9 groups. Chelation rate analysis showed that the Sr/dSIS-7 group had the highest strontium chelation rate, which was statistically different from the other groups (P < 0.05). The scaffolds in all the groups had good water absorption. The scaffolds in Sr/dSIS-5, -7 and -9 groups showed significantly improved mechanical properties compared with the control group (P < 0.05). The scaffolds in all the groups had good biocompatibility, and the Sr/dSIS-7 group showed the best proliferation of BMSCs.@*CONCLUSION@#When pH was 7, the Sr/dSIS scaffolds showed the highest strontium chelation rate and the best proliferation effect of BMSCs, which was the ideal pH value for the preparation of the Sr/dSIS scaffolds.


Subject(s)
Tissue Scaffolds/chemistry , Biocompatible Materials , Strontium/pharmacology , Ions , Hydrogen-Ion Concentration , Tissue Engineering/methods , Porosity
3.
Journal of Peking University(Health Sciences) ; (6): 378-383, 2021.
Article in Chinese | WPRIM | ID: wpr-942190

ABSTRACT

OBJECTIVE@#To evaluate the biocompatibility and osteogenic effect of new calcium phosphate cement (CPC) in vivo and to provide experimental basis for its further clinical application.@*METHODS@#Thirty New Zealand white rabbits were randomly divided into four groups: CPC group, CPC+Bio-Oss group, Bio-Oss group and blank control group. Bone defect models of 6 mm in diameter and 7 mm in depth were made on the lateral condyle of bilateral hind legs of the rabbits. CPC, Bio-Oss and CPC+Bio-Oss mixture were implanted into the bone defect according to the group, and the mass ratio of CPC and Bio-Oss was 4 ∶ 1. The experimental animals were sacrificed the 4th, 12th and 24th week after operation. The tissue around the bone defect was taken for histological evaluation by H&E staining. Bone ingrowth fraction (BIF) was calculated. The expression of BMP-2 and COL-Ⅰ was detected by immunohis- tochemical staining by calculating the mean optical density (MOD) of the positive area the 4th week after operation, and the bone healing of each group was evaluated at different time points. The measurement data were analyzed by one-way ANOVA and LSD test was used for multiple comparison of the differences between the means by SPSS 19.0. P < 0.05 was considered to be statistically significant.@*RESULTS@#The results of H&E staining showed that the BIF values of CPC group, CPC + Bio-Oss group and Bio-Oss group were significantly higher than those of blank control group at the same time point (P < 0.01). The BIF values of CPC group were lower than those of Bio-Oss group and CPC + Bio-Oss group (P < 0.01). There was no significant difference between CPC + Bio-Oss group and Bio-Oss group. Immunohistochemical staining showed that the MOD values of BMP-2 and COL-Ⅰ in CPC group were higher than those in blank control group, but lower than those in Bio-Oss group and CPC+Bio-Oss group (P < 0.01). There was no significant difference between BMP-2 and COL-Ⅰ in CPC+Bio-Oss group and Bio-Oss group.@*CONCLUSION@#The new calcium phosphate cement has good biocompatibility and can promote early osteogenesis with stable and long-term effect.


Subject(s)
Animals , Rabbits , Bone Cements , Calcium , Calcium Phosphates , Osteogenesis , Strontium
4.
Belo Horizonte; s.n; 2020. 146 p. ilus, tab.
Thesis in Portuguese | LILACS, BBO | ID: biblio-1223495

ABSTRACT

A incorporação de íons na estrutura da hidroxiapatita (HA) pode afetar sua estrutura, cristalinidade, solubilidade e citotoxicidade. Dentre os íons presentes na composição da apatita óssea, o magnésio (Mg2+), estrôncio (Sr2+) e zinco (Zn2+) são reconhecidos por promover a angiogênese e osteogênese. Portanto, as HAs substituídas podem apresentar melhor bioatividade, por fornecer íons com potencial de estimular a neoformação óssea nos locais enxertados. Nesse contexto, este estudo descreve a síntese, caracterização e comparação de uma série de nano-hidroxiapatitas (nHAs) substituídas e co-substituídas por Sr2+, Mg2+ ou Zn2+. Em seguida, foi desenvolvido um cimento ósseo à base das HAs com melhores resultados de citotoxicidade, associado ao DCPA, gelatina e quitosana. As nHAs foram caracterizadas físico-quimicamente usando diferentes técnicas. O método de co-precipitação foi eficaz para sintetizar HAs de dimensões nanométricas. Comparado a nHA pura, os difratogramas, espectros de FTIR e parâmetros de rede das nHAs substituídas e co-substituídas exibiram alterações, indicando que a incorporação de cátions resultou em distorções da rede da HA. Os testes de MTT demonstraram que as nHAs sintetizadas não foram citotóxicas, após contato direto com culturas de fibroblastos (L929) e pré-osteoblastos (MC3T3). Os resultados obtidos sugerem que as nHAs co-substituídas por Mg2+/Sr2+ e Zn2+/Sr2+ parecem induzir maior proliferação de células fibroblásticas e osteoblásticas, quando comparado a HA pura e substituída. Os cimentos ósseos desenvolvidos apresentaram capacidade de auto-endurecimento e resistência à lavagem. Além de possuírem alta molhabilidade e um perfil de liberação de íons Ca2+, Sr2+, Mg2+ e Zn2+, que está dentro das doses indicadas para estimular a proliferação de osteoblastos. Os cimentos exibiram excelente biocompatibilidade in vitro em culturas de células fibroblásticas, endoteliais e osteosblásticas. Os cimentos contendo nHAs co-substituídas por Mg2+/Sr2+ exibiram os melhores resultados de viabilidade celular. Após 24 horas de contato indireto com cultura de células fibroblásticas L929, o crescimento celular do grupo C2 foi maior que de todos os grupos em estudo (P < 0,01). Em cultura de células endoteliais EA.hy926, o percentual de células viáveis do grupo C3 foi significativamente maior que de todos os outros grupos, após 24 horas (p < 0,001). A citotoxicidade indireta em cultura de células pré-osteoblásticas MC3T3 revelou que após 48 horas, o grupo C3 apresentou maior viabilidade celular que todos os grupos em estudo (p < 0,01). O teste de formação de tubo sugere que todos os cimentos desenvolvidos possuem potencial angiogênico, sendo que os cimentos contendo nHAs co-substituídas por Zn2+/Sr2+ exibiram resultados significativamente superiores (p < 0,001). Apesar de ser necessário um maior número de testes de biocompatibilidade; a incorporação de íons na rede cristalina das nHAs, que são reconhecidos por afetar a angiogênese e a osteogênese, parece ter resultado no desenvolvimento de cimentos ósseos com potencial para promover a regeneração óssea.


The incorporation of ions into the HA lattice can affect its structure, crystallinity, solubility and cytotoxicity. From the ions present in the composition of bone apatite, Mg2+, Sr2+ and Zn2+ are recognized for promoting angiogenesis and osteogenesis. The substituted HAs can be present better bioactivity for supplying ions with potential to stimulate bone neoformation in grafted sites. This study described the synthesis, characterization and comparison of a range of substituted and co-substituted nHAs contained Sr2+, Mg2+ or Zn2+. Then, it developed bone cement based on HAs with better cytotoxicity results, associated with DCPA, gelatin and chitosan. The nHAs were physicochemically characterized using different techniques. The co-precipitation method was effective for synthesizing HAs with nanometric dimensions. Compared to pure nHA, the diffractograms, FTIR spectra and lattice parameters of the substituted and co-substituted nHAs showed changes, indicating that the incorporation of cations resulted in distortions of the HA lattice. MTT tests demonstrated that the all synthesized nHAs were not cytotoxic after direct contact with fibroblasts (L929) and pre-osteoblasts (MC3T3) cultures. MTT results suggest that Mg2+/Sr2+ and Zn2+/Sr2+ co-substituted nHAs seem to induce more proliferation of fibroblastic and osteoblastic than pure and Mg2+, Sr2+ and Zn2+ substituted nHAs. Bone cements developed showed self-hardening and washout resistance. Also, they Exhibited high wettability and ion release profile with non-toxic concentrations of Ca2+, Sr2+, Mg2+ and Zn2+, range within indicated doses to stimulate the proliferation of osteoblasts. The cement exhibited excellent in vitro cytocompatibility in fibroblastic, endothelial and osteoblastic cell cultures. Cement containing Mg2+/Sr2+ co-substituted nHAs showed better results of the cell viability. After 24 hours of indirect contact with L929 fibroblast culture, the cell growth in the C2 group was highest than all study groups (P <0.01). In EA.hy926 endothelial culture, the cell viability of the C3 group was significantly highest than all other groups after 24 hours (p <0.001). The indirect cytotoxicity in MC3T3 pre-osteoblastic culture revealed that after 48 hours, the C3 group showed the greatest cell viability than all the study groups (p <0.01). The tube formation assay suggests that all cement have angiogenic potential, being that the cements containing Zn2+ / Sr2+ co-substituted nHAs exhibited significantly better results (p < 0,001). Despite being necessary to perform a more significant number of biocompatibility tests, the incorporation of ions into the nHA lattice, which are recognized for affects angiogenesis and osteogenesis, may have resulted in the development of bone cements with the potential to promoting bone regeneration.


Subject(s)
Osteogenesis , Apatites , Bone Cements , Bone Regeneration , Hydroxyapatites , Strontium , Zinc , Magnesium
5.
Journal of Bone Metabolism ; : 15-26, 2020.
Article in English | WPRIM | ID: wpr-811188

ABSTRACT

A systematic search was conducted and relevant studies that evaluated the influence of osteoporosis medications (bisphosphonates [BPs], denosumab, selective estrogen receptor modulators [SERMs], recombinant human parathyroid hormone teriparatide [TPTD], and strontium ranelate [SrR]) on wrist, hip, and spine fracture healing, were selected. BPs administration did not influence fracture healing and clinical outcomes after distal radius fracture (DRF). Similar results were observed in hip fracture, but evidence is lacking for spine fracture. Denosumab did not delay the non-vertebral fractures healing in one well-designed study. No studies evaluated the effect of SERMs on fracture healing in humans. One study reported shorter fracture healing times in TPTD treated DRF patients, which was not clinically meaningful. In hip fracture, recent studies reported better pain and functional outcomes in TPTD treated patients. However, in spine fracture, recent studies found no significant differences in fracture stability between TPTD treated patients and controls. Evidence is lacking for SrR, but it did not influence wrist fracture healing in one study. In comparisons between TPTD and BPs, fracture healing and physical scores were not significantly different in hip fracture by 1 study. In spine fracture, controversy exists for the role of each medication to the fracture stability, but several studies reported that fracture site pain was better in TPTD treated patients than BPs treated patients. Considering no clinical data of negative fracture healing of the antiresorptive medication and the danger of subsequent fracture after initial osteoporotic fracture, there is no evidence to delay initiation of osteoporosis medications after fracture.


Subject(s)
Humans , Denosumab , Diphosphonates , Fracture Healing , Hip , Osteoporosis , Osteoporotic Fractures , Parathyroid Hormone , Radius Fractures , Selective Estrogen Receptor Modulators , Spine , Strontium , Teriparatide , Wrist
6.
West China Journal of Stomatology ; (6): 697-703, 2020.
Article in Chinese | WPRIM | ID: wpr-878397

ABSTRACT

Strontium (Sr) is an essential trace element and widely exists in nature. It plays an important role in the in vivo regulation of bone metabolism. Sr locates below Fe in the periodic table, and its chemical structure and polarity are similar to those of Ca. It can induce bone mesenchymal stem cells to differentiate into osteoblasts by inhibiting the activity of osteoclasts and reducing bone resorption. It promotes bone formation through a series of related pathways. The mechanism of Sr regulation of bone metabolism has been extensively researched in recent years. The current study aims to investigate the mechanism of Sr and provide a theoretical basis for its clinical application.


Subject(s)
Humans , Bone Resorption , Osteoblasts , Osteoclasts , Osteogenesis , Strontium
7.
Tissue Engineering and Regenerative Medicine ; (6): 237-251, 2019.
Article in English | WPRIM | ID: wpr-761906

ABSTRACT

BACKGROUND: Nowadays, production of nanocomposite scaffolds based on natural biopolymer, bioceramic, and metal ions is a growing field of research due to the potential for bone tissue engineering applications. METHODS: In this study, a nanocomposite scaffold for bone tissue engineering was successfully prepared using collagen (COL), beta-tricalcium phosphate (β-TCP) and strontium oxide (SrO). A composition of β-TCP (4.9 g) was prepared by doping with SrO (0.05 g). Biocompatible porous nanocomposite scaffolds were prepared by freeze-drying in different formulations [COL, COL/β-TCP (1:2 w/w), and COL/β-TCP-Sr (1:2 w/w)] to be used as a provisional matrix or scaffold for bone tissue engineering. The nanoparticles were characterized by X-ray diffraction, Fourier transforms infrared spectroscopy and energy dispersive spectroscopy. Moreover, the prepared scaffolds were characterized by physicochemical properties, such as porosity, swelling ratio, biodegradation, mechanical properties, and biomineralization. RESULTS: All the scaffolds had a microporous structure with high porosity (~ 95–99%) and appropriate pore size (100–200 µm). COL/β-TCP-Sr scaffolds had the compressive modulus (213.44 ± 0.47 kPa) higher than that of COL/β-TCP (33.14 ± 1.77 kPa). In vitro cytocompatibility, cell attachment and alkaline phosphatase (ALP) activity studies performed using rat bone marrow mesenchymal stem cells. Addition of β-TCP-Sr to collagen scaffolds increased ALP activity by 1.33–1.79 and 2.92–4.57 folds after 7 and 14 days of culture, respectively. CONCLUSION: In summary, it was found that the incorporation of Sr into the collagen-β-TCP scaffolds has a great potential for bone tissue engineering applications.


Subject(s)
Animals , Rats , Alkaline Phosphatase , Biopolymers , Bone and Bones , Bone Marrow , Collagen , Fourier Analysis , Freeze Drying , In Vitro Techniques , Ions , Mesenchymal Stem Cells , Nanocomposites , Nanoparticles , Porosity , Spectrum Analysis , Strontium , X-Ray Diffraction
8.
Tissue Engineering and Regenerative Medicine ; (6): 161-175, 2019.
Article in English | WPRIM | ID: wpr-761894

ABSTRACT

BACKGROUND: Lonocyte-derived multipotential cells (MOMCs) include progenitors capable of differentiation into multiple cell lineages and thus represent an ideal autologous transplantable cell source for regenerative medicine. In this study, we cultured MOMCs, generated from mononuclear cells of peripheral blood, on the surface of nanocomposite thin films. METHODS: For this purpose, nanocomposite Poly(e-caprolactone) (PCL)-based thin films containing either 2.5 wt% silica nanotubes (SiO2ntbs) or strontium hydroxyapatite nanorods (SrHAnrds), were prepared using the spin-coating method. The induced differentiation capacity of MOMCs, towards bone and endothelium, was estimated using flow cytometry, real-time polymerase chain reaction, scanning electron microscopy and fluorescence microscopy after cells' genetic modification using the Sleeping Beauty Transposon System aiming their observation onto the scaffolds. Moreover, Wharton's Jelly Mesenchymal Stromal Cells were cultivated as a control cell line, while Human Umbilical Vein Endothelial Cells were used to strengthen and accelerate the differentiation procedure in semi-permeable culture systems. Finally, the cytotoxicity of the studied materials was checked with MTT assay. RESULTS: The highest differentiation capacity of MOMCs was observed on PCL/SiO2ntbs 2.5 wt% nanocomposite film, as they progressively lost their native markers and gained endothelial lineage, in both protein and transcriptional level. In addition, the presence of SrHAnrds in the PCL matrix triggered processes related to osteoblast bone formation. CONCLUSION: To conclude, the differentiation of MOMCs was selectively guided by incorporating SiO2ntbs or SrHAnrds into a polymeric matrix, for the first time.


Subject(s)
Autografts , Beauty , Cell Line , Cell Lineage , Durapatite , Endothelium , Flow Cytometry , Human Umbilical Vein Endothelial Cells , Mesenchymal Stem Cells , Methods , Microscopy, Electron, Scanning , Microscopy, Fluorescence , Nanocomposites , Nanotubes , Osteoblasts , Osteogenesis , Polymers , Real-Time Polymerase Chain Reaction , Regenerative Medicine , Silicon Dioxide , Strontium , Wharton Jelly
9.
J. appl. oral sci ; 26: e20170084, 2018. graf
Article in English | LILACS, BBO | ID: biblio-893718

ABSTRACT

ABSTRACT Objective: This study aimed to evaluate bone repair in rat dental sockets after implanting nanostructured carbonated hydroxyapatite/sodium alginate (CHA) and nanostructured carbonated hydroxyapatite/sodium alginate containing 5% strontium microspheres (SrCHA) as bone substitute materials. Methods: Twenty male Wistar rats were randomly divided into two experimental groups: CHA and SrCHA (n=5/period/group). After one and 6 weeks of extraction of the right maxillary central incisor and biomaterial implantation, 5 μm bone blocks were obtained for histomorphometric evaluation. The parameters evaluated were remaining biomaterial, loose connective tissue and newly formed bone in a standard area. Statistical analysis was performed by Mann-Withney and and Wilcoxon tests at 95% level of significance. Results: The histomorphometric results showed that the microspheres showed similar fragmentation and bio-absorbation (p>0.05). We observed the formation of new bones in both groups during the same experimental periods; however, the new bone formation differed significantly between the weeks 1 and 6 (p=0.0039) in both groups. Conclusion: The CHA and SrCHA biomaterials were biocompatible, osteoconductive and bioabsorbable, indicating their great potential for clinical use as bone substitutes.


Subject(s)
Animals , Male , Strontium/pharmacology , Bone Regeneration/drug effects , Carbonates/pharmacology , Durapatite/pharmacology , Bone Substitutes/pharmacology , Tooth Socket/drug effects , Nanostructures/therapeutic use , Alginates/pharmacology , Osteogenesis/drug effects , Osteogenesis/physiology , Strontium/chemistry , Time Factors , Bone Regeneration/physiology , Carbonates/chemistry , Random Allocation , Reproducibility of Results , Bone Transplantation/methods , Treatment Outcome , Rats, Wistar , Spectroscopy, Fourier Transform Infrared , Durapatite/chemistry , Bone Substitutes/chemistry , Tooth Socket/physiology , Glucuronic Acid/pharmacology , Glucuronic Acid/chemistry , Nanostructures/chemistry , Alginates/chemistry , Hexuronic Acids/pharmacology , Hexuronic Acids/chemistry
10.
Biomedical and Environmental Sciences ; (12): 483-488, 2018.
Article in English | WPRIM | ID: wpr-690630

ABSTRACT

A magnetic metal organic framework (MMOF) was synthesized and used to separate Sr2+ in aqueous solution. The shape and structure of prepared Fe3O4@UiO-66-NH2 were characterized, and the absorbed concentration of strontium was determined through inductively coupled plasma mass spectrometry. The results indicated that Fe3O4 and UiO-66-NH2 combined through chemical bonding. The experimental adsorption results for separation of Sr2+ in aqueous solution indicated that the adsorption of Sr2+ to Fe3O4@UiO-66-NH2 increased drastically from pH 11 to pH 13. The adsorption isotherm model indicated that the adsorption of Sr2+ conformed to the Freundlich isotherm model (R2 = 0.9919). The MMOF thus inherited the superior qualities of magnetic composites and metal organic frameworks, and can easily be separated under an external magnetic field. This MMOF thus has potential applications as a magnetic adsorbent for low level radionuclide 90Sr.


Subject(s)
Adsorption , Ferrosoferric Oxide , Chemistry , Hydrogen-Ion Concentration , Metal-Organic Frameworks , Chemistry , Models, Theoretical , Nanoparticles , Chemistry , Strontium , Surface Properties , Water Pollutants, Radioactive , Water Purification , Methods
11.
Actual. osteol ; 13(3): 198-206, Sept - DIc. 2017. graf, tab
Article in Spanish | LILACS | ID: biblio-1117027

ABSTRACT

La osteoporosis afecta al 6-7% de la población masculina. Es alta la proporción de pacientes con fracturas sin diagnóstico previo de esta enfermedad. La mortalidad luego de una fractura es mayor en hombres que en población femenina; a pesar de esto, la mayoría de los pacientes no reciben tratamiento. Los fármacos aprobados, en nuestro medio, para tratar la osteoporosis masculina son: bifosfonatos, teriparatida y ranelato de estroncio. El objetivo de este estudio fue evaluar el efecto del ranelato de estroncio sobre la densidad mineral ósea en hombres después de 1 año de tratamiento. Se incluyeron los registros de 20 hombres de 67,8±3,0 años, tratados con ranelato de estroncio (2 g/día) durante 1 año. Todos los pacientes presentaban un T-score inferior a -2,5 en cadera o columna vertebral o un T-score inferior a -2,0 y factores de riesgo de fractura. No hubo modificación de parámetros de laboratorio luego del tratamiento (calcemia, calciuria, fósforo sérico, parathormona, 25(OH)vitamina D, fosfatasa alcalina y desoxipiridinolina) en relación a los basales. Luego del tratamiento con ranelato de estroncio se observó incremento de la densidad mineral ósea en columna lumbar: 0,953±0,029 versus 0,997±0,030 g/cm2 (p=0,0068), cuello femoral: 0,734±0,013 versus 0,764±0,016 g/cm2 (p=0,0084) y cadera total: 0,821±0,02 versus 0,834±0,02 g/cm2 (p=0,0419). Conclusión: el tratamiento con ranelato de estroncio produjo un incremento significativo de la densidad mineral ósea en columna lumbar y fémur proximal en hombres con osteoporosis. (AU)


Osteoporosis affects 6-7% of the male population. The proportion of patients with fragility fractures but without diagnosis of the disease is high. Mortality after hip fracture is higher in men than in women; in spite of this, most patients are left without treatment for osteoporosis. Drugs approved, for the treatment of osteoporosis in our country are bisphosphonates, teriparatide, and strontium ranelate (SrR). The objective of this study was to evaluate the effect of SrR on axial BMD in men after one year of treatment. We obtained pertinent data from medical registries of 20 men aged 67,8±3,0 years, treated with oral SrR (2 g/day) for 12 months. All patients had a T-score below -2,5 at the hip or the lumbar spine, or a T-score below -2,0 and one or more risk factors for fracture. The levels of serum calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D, or PTH, or urinary calcium and desoxipyridinoline remained unchanged following SrR administration. After treatment with SrR there were significant increases in BMD at the lumbar spine: 0,953±0,029 versus 0,997±0,030 g/cm2 (p=0,0068), femoral neck: 0,734±0,013 versus 0,764±0,016 g/cm2 (p=0.0084), and total hip: 0,821±0,02 versus 0,834±0,02 g/cm2 (p=0,0419). Conclusion: in osteoporotic men, treatment with SrR significantly increases BMD in the lumbar spine and the proximal femur. (AU)


Subject(s)
Humans , Male , Aged , Osteoporosis/drug therapy , Strontium/chemistry , Bone Diseases, Metabolic/drug therapy , Bone Density/drug effects , Organometallic Compounds , Osteoporosis/diagnosis , Argentina , Strontium/administration & dosage , Testosterone/therapeutic use , Thiophenes , Vitamin D/administration & dosage , Bone Diseases, Metabolic/metabolism , Bone Diseases, Metabolic/blood , Body Mass Index , Sex Factors , Calcium/administration & dosage , Retrospective Studies , Risk Factors , Bone Density Conservation Agents/therapeutic use , Osteoporotic Fractures , Hypogonadism/complications
13.
Femina ; 45(2): 82-89, jun. 2017. ilus
Article in Portuguese | LILACS | ID: biblio-1415432

ABSTRACT

Osteoporose é um problema de saúde pública importante que acomete mais de metade das mulheres com idade superior a 50 anos. Doença com um enorme impacto sobre a saúde pública, através da morbidade e mortalidade aumentadas, com custos econômicos associados resultantes das fraturas. O objetivo é avaliar e identificar as pessoas de risco para desenvolver fraturas osteoporóticas de fragilidade que necessitam ser tratadas. A abordagem de mulheres com baixa massa óssea e aumento do risco de fraturas deve ser multidisciplinar. A farmacoterapia é apenas uma Steiner ML, Strufaldi R, Fernandes CE das possíveis intervenções. Aspectos como a nutrição orientada, fortalecimento muscular, prevenção de quedas, suplementos vitamínicos e minerais devem ser considerados. O tratamento farmacológico permite a prevenção da perda óssea, a prevenção primária e secundária de fragilidade óssea e deve ser baseado na avaliação do risco de fratura do indivíduo e na relação custo-benefício do medicamento escolhido.


Osteoporosis is a significant public health problem that affects more than half of women aged over 50. This disease has a huge impact on public health through morbidity and increased mortality, and economic costs associated with the resulting fractures. The goal is to assess and identify risk people to develop osteoporotic fragility fractures that need to be addressed. The approach of women with low bone mass and increased risk of fractures should be multidisciplinary. Pharmacotherapy is just one of the possible interventions. Aspects such as the guidance nutrition, muscle strengthening, prevention of falls, mineral and vitamin supplements should be considered. Pharmacological treatment allows preventing bone loss and primary and secondary prevention of osteoporosis and should be based on risk factors and pharmaceutical cost benefit analysis.


Subject(s)
Humans , Female , Middle Aged , Aged , Aged, 80 and over , Osteoporosis/drug therapy , Osteoporosis, Postmenopausal/drug therapy , Osteoporotic Fractures/prevention & control , Parathyroid Hormone/therapeutic use , Strontium/therapeutic use , Risk Groups , Calcitonin/therapeutic use , Estrogen Replacement Therapy , Risk Factors , Selective Estrogen Receptor Modulators , Diphosphonates/therapeutic use , Denosumab/therapeutic use
14.
Cienc. tecnol. salud ; 4(1): 49-57, 20170600. tab
Article in Spanish | LILACS | ID: biblio-882836

ABSTRACT

El selenio (Se) es un elemento esencial para el ser humano que se encuentra en pequeñas cantidades en los suelos, pero se acumula en ciertas plantas, proporcionando beneficios como antioxidante, antiinflamatorio y quemopreventivo por la presencia de unas 25 selenoproteínas que participan en diversas acciones de bienestar, lactancia, desarrollo, reproducción y salud de la progenie. El objetivo de este estudio fue evaluar el contenido de Se en hojas de vegetales utilizados tradicionalmente en la alimentación guatemalteca. Se colectaron hojas de materiales cultivados para los mercados locales de nueve hierbas nativas (Amaranthus hybridus, Cnidoscolus aconitifolius, Crotalaria longirostrata, Dysphania ambrosioides, Lycianthes synanthera, Sechium edule, Solanum americanum, Solanum nigrescens y Solanum wendlandii) y dos introducidas de reconocido uso alimenticio (Moringa oleifera y Spinacia oleracea), se secaron en un horno de convección forzada para lograr una humedad < 10% y se digirieron 0.25 ± 0.02 g de hojas en una mezcla de ácido nítrico y ácido perclórico que se calentó hasta la digestión total de la materia. El Se fue determinado por el método de reflexión total de rayos X, utilizando un estándar interno de itrio (Y) el que se midió utilizando reflectores de cuarzo en un espectrómetro de reflexión total de rayos X. De todas las especies evaluadas, únicamente A. hybridus demostró cantidades cuantificables de Se. Se determinó que 100 g de materia vegetal seca de A. hybridus proporciona 0.355 mg de Se, por lo que su consumo semanal puede contribuir con el requerimiento de este micronutriente para un adulto.


Selenium (Se) is an essential element for the human being; it is in small amounts in the soil but it accumulates in certain plants, providing benefits as antioxidant, anti-inflammatory and chemopreventive, due to the presence of about 25 selenoproteins that participate in different welfare and development actions, lactation, reproduction and health of the progeny. This study aimed to assess Se content in leaves of nine native plants traditionally used in Guatemalan food (Amaranthus hybridus, Cnidoscolus aconitifolius, Crotalaria longirostrata, Dysphania ambrosioides, Lycianthes synanthera, Sechium edule, Solanum americanum, Solanum nigrescens and Solanum wendlandii) and two internationally uses herbs (Moringa oleifera, Spinacia oleracea). Se was determined by total reflection X-ray method. Plants were dried in a forced convection oven to constant weight, then were digested by weighing 0.25 ± 0.02 g of dry plant material with a mixture of nitric and perchloric acid, and warmed to achieve complete digestion. Using a yttrium (Y) internal standard were measured using quartz reflectors Spectrometer Total reflection X-ray. Of all native plant species tested, only A. hybridus there were measurable amounts of Se. It was determined that 100 g of dry plant material of A. hybridus provides 0.355 mg of Se, so its weekly consumption by an adult might contribute to satisfied the requirement of this microelement.


Subject(s)
Humans , Male , Female , Rubidium/administration & dosage , Strontium/analysis , Amaranthus/growth & development , Plants, Edible/classification
15.
Actual. osteol ; 13(1): 9-16, Ene - Abr. 2017. tab
Article in Spanish | LILACS | ID: biblio-1118618

ABSTRACT

Tanto el ranelato de estroncio (RSr) como el denosumab (Dmab) son eficaces en el tratamiento de la osteoporosis (OP) posmenopáusica (PM). El efecto de cada fármaco por separado sobre la densidad mineral ósea (DMO) ha sido estudiado recientemente. Con ambas drogas se observó, al año de tratamiento, un aumento significativo de la DMO en columna lumbar (CL), cuello femoral (CF) y cadera total (CT). En este trabajo comparamos la respuesta densitométrica al año de tratamiento con una y otra droga. Utilizamos los registros de 425 pacientes PMOP tratadas con Dmab y 441 tratadas con RSr. En cada paciente analizamos el porcentaje de cambio; se clasificaron como respondedoras aquellas que mostraron un cambio ≥3%. Adicionalmente se comparó la respuesta en pacientes no previamente tratadas con bifosfonatos (BF-naïve) en comparación con pacientes que habían recibido previamente un BF. Al analizar el grupo completo para Dmab, el porcentaje de pacientes respondedoras fue de 68,4% en CL, 63,3% en CF y 49,3% en CT. Por otro lado, en el grupo de pacientes tratadas con RSr, el porcentaje de respondedoras (53,8% en CL, 40,0% en CF y 35,6% en CT) fue estadísticamente menor. Cuando comparamos la respuesta entre las pacientes BF-naïve que recibieron RSr o Dmab, el Dmab indujo mayor respuesta en CL y CF que el grupo RSr, sin diferencias en CT. Cuando se analizaron los subgrupos BF-previo, las tratadas con Dmab mostraron mayor respuesta en todas las regiones. Conclusión: en pacientes con OP-PM, el tratamiento con Dmab produjo mayores incrementos densitométricos que el RSr, siendo el porcentaje de pacientes respondedoras mayor con Dmab que con RSr. (AU)


Both strontium ranelate (SrR) and denosumab (Dmab) are effective in the treatment of postmenopausal osteoporosis (PMOP). The effect of each drug on bone mineral density (BMD) has been studied separately by us. With both treatments, there was a significant increase after one year of treatment at the lumbar spine (LS) and hip. In this paper we compared the densitometric response after one year of treatment with both drugs used separately. We used the clinical records of 425 PM patients treated with Dmab and 441 treated with SrR. For each patient we analyzed the percentage of change; those who showed a change ≥3% were classified as responders. Additionally, the response was compared in patients not previously treated with bisphosphonates (BP-naïve) compared to patients who had previously received a BP. When analyzing the complete group for Dmab, the percentage of "responders" was 65.2% at the LS, 62.9% at the femoral neck (FN) and 47.4% at the total hip (TH). On the other hand, in the group of patients treated with SrR the percentage of responders (53.8% at the LS, 40.0% at the FN and 35.6% at the TH) was statistically lower. When comparing the response between in BF-naïve patients receiving RSr or Dmab, Dmab induced a greater response at the LS and FN than the RSr group, with no statistical differences at the TH. When the subgroups with prior BP treatment were analyzed, those treated with Dmab showed greater response in all regions. Conclusion: in patients with PMOP treatment with Dmab produced greater densitometric increments than SrR, and the percentage of responders was higher with Dmab than with SrR. (AU)


Subject(s)
Humans , Female , Middle Aged , Aged , Aged, 80 and over , Strontium/therapeutic use , Osteoporosis, Postmenopausal/drug therapy , Denosumab/therapeutic use , Phosphates/blood , Strontium/administration & dosage , Strontium/chemistry , Vitamin D/administration & dosage , Biomarkers , Bone Density/drug effects , Fractures, Stress/prevention & control , Osteocalcin/blood , Osteoporosis, Postmenopausal/blood , Calcium/administration & dosage , Calcium/blood , Retrospective Studies , Teriparatide/therapeutic use , Densitometry , Diphosphonates/therapeutic use , Alkaline Phosphatase/blood , Bone Density Conservation Agents/therapeutic use , Femur Neck/drug effects , Denosumab/administration & dosage , Treatment Adherence and Compliance , Hip , Lumbosacral Region
16.
ImplantNewsPerio ; 2(2): 301-308, mar.-abr. 2017.
Article in Portuguese | LILACS, BBO | ID: biblio-847154

ABSTRACT

O tratamento de defeitos ósseos intrabucais tem sido um desafi o na área odontológica, e a pesquisa de novas drogas para otimizar os resultados cirúrgicos regenerativos é de extrema importância. Existem evidências de que algumas drogas, como o ranelato de estrôncio (RSr), a sinvastatina (SNV) e o alendronato de sódio (ALE), têm propriedades anabólicas no metabolismo ósseo. A proposta desta revisão foi apresentar o estado atual da arte sobre o emprego da SNV, do RSr e do ALE em terapias odontológicas. Foi realizada uma busca bibliográfica na base PubMed e incluídos estudos relevantes relacionados ao tema para síntese deste trabalho. Concluiu-se que a aplicação do ALE e da SIN são efetivos como coadjuvantes no tratamento mêcanico da doença periodontal e como indutores de neoformação óssea, entretanto, o RSr merece ser mais bem estudado para tal afirmação.


The treatment of intraoral bone defects has been a challenge in dentistry, in this way the development of new drugs in order to optimize surgical regenerative results are extreme important. There are evidences that drugs such as strontium ranelate (RSr), simvastatin (SNV) and sodium alendronate (ALE) have anabolic properties in bone metabolism and several studies have been performed aiming to improve therapeutic strategies in bone regeneration. Therefore, the purpose of this review is to present the current state of art about the usage of SNV, RSr and ALE in dental therapies, targeting better clinical outcomes in bone manipulation techniques. A literature research was performed in PubMed database and relevant studies between were included. Our study concluded that application of ALE and SNV are effective as adjuncts with mechanical therapy of periodontal disease and also induces bone formation. In the other hand, the application of RSr as a promising bone formation drug needs to be better elucidated.


Subject(s)
Humans , Alendronate/therapeutic use , Bone Regeneration/drug effects , Periodontitis/drug therapy , Simvastatin/therapeutic use , Strontium/therapeutic use
17.
Braz. oral res. (Online) ; 30(1): e45, 2016. graf
Article in English | LILACS | ID: biblio-951999

ABSTRACT

Abstract The aim of this study is to evaluate the biocompatibility and osteoconductivity in surgical defects of sheep tibias filled with 1% strontium-containing nanostructured hydroxyapatite microspheres (SrHA), stoichiometric hydroxyapatite without strontium microspheres (HA), or blood clots. Santa Ines sheep were subjected to three perforations on the medial side of the left tibia. The biomaterials were characterized by X-ray Diffraction (XRD) and Fourier Transform Infrared (FTIR) before implantation and by X-Ray Microfluorescence (µFRX) and Scanning Electron Microscopy (SEM) after sheep tibias implantation. Surgical defects were filled with blood clots (control), SrHA (Group 1) or HA (Group 2). After 30 days, 5-µm bone blocks were obtained for histological evaluation, and the blocks obtained from 1 animal were embedded in methylmethacrylate for undecalcified sections. Mononuclear inflammatory infiltrate remained mild in all experimental groups. Giant cells were observed surrounding biomaterials particles of both groups and areas of bone formation were detected in close contact with biomaterials. All groups showed newly formed bone from the periphery to the center of the defects, which the control, HA and SrHA presented 36.4% (± 21.8), 31.2% (± 14.7) and 26.2% (± 12.9) of newly formed bone density, respectively, not presenting statistical differences. In addition, the connective tissue density did not show any significant between groups. The SrHA showing a higher volume density of biomaterial (51.2 ± 14.1) present in the defect compared to HA (32.6 ± 8.5) after 30 days (p = 0.03). Microspheres containing 1% SrHA or HA can be considered biocompatible, have osteoconductive properties and may be useful biomaterials for clinical applications.


Subject(s)
Animals , Female , Strontium/pharmacology , Wound Healing/drug effects , Bone Regeneration/drug effects , Bone Substitutes/pharmacology , Nanostructures/chemistry , Hydroxyapatites/pharmacology , Tibia/drug effects , Time Factors , X-Ray Diffraction , Materials Testing , Sheep , Microscopy, Electron, Scanning , Reproducibility of Results , Spectroscopy, Fourier Transform Infrared , Models, Animal , X-Ray Microtomography
18.
Restorative Dentistry & Endodontics ; : 255-261, 2016.
Article in English | WPRIM | ID: wpr-170672

ABSTRACT

OBJECTIVES: This study aimed to analyze the mineral composition of naturally- and artificially-produced caries-affected root dentin and to determine the elemental incorporation of resin-modified glass ionomer (RMGI) into the demineralized dentin. MATERIALS AND METHODS: Box-formed cavities were prepared on buccal and lingual root surfaces of sound human premolars (n = 15). One cavity was exposed to a microbial caries model using a strain of Streptococcus mutans. The other cavity was subjected to a chemical model under pH cycling. Premolars and molars with root surface caries were used as a natural caries model (n = 15). Outer caries lesion was removed using a carbide bur and a hand excavator under a dyeing technique and restored with RMGI (FujiII LC, GC Corp.). The weight percentages of calcium (Ca), phosphate (P), and strontium (Sr) and the widths of demineralized dentin were determined by electron probe microanalysis and compared among the groups using ANOVA and Tukey test (p < 0.05). RESULTS: There was a pattern of demineralization in all models, as visualized with scanning electron microscopy. Artificial models induced greater losses of Ca and P and larger widths of demineralized dentin than did a natural caries model (p < 0.05). Sr was diffused into the demineralized dentin layer from RMGI. CONCLUSIONS: Both microbial and chemical caries models produced similar patterns of mineral composition on the caries-affected dentin. However, the artificial lesions had a relatively larger extent of demineralization than did the natural lesions. RMGI was incorporated into the superficial layer of the caries-affected dentin.


Subject(s)
Humans , Bicuspid , Calcium , Dentin , Electron Probe Microanalysis , Glass , Hand , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Miners , Models, Chemical , Molar , Root Caries , Streptococcus mutans , Strontium
20.
The Philippine Journal of Nuclear Medicine ; : 31-34, 2016.
Article | WPRIM | ID: wpr-962158

ABSTRACT

Metastatic bone disease is a major sequela of several malignancies, such as the prostate, breast, lung, kidney and thyroid. Bone pain is a common symptom in advancing malignancy and often determines the quality of life in the later stages of disease. Management of bone pain from metastasis remains palliative at present. With the improved cancer survival resulting from advances in cancer management, the population of patients seeking relief of bone pain has increased. Radiopharmaceutical therapy offers potential pain relief with minimal adverse effects. This is a case report on the clinical utility of strontium-89 chloride for the palliation of bone pain in metastatic prostate cancer. A 67-year-old male presented with bone pain due to disseminated bone metastases form prostate cancer, most intense in the lower back (Visual Analogue Scale pain score of 8). Strontium-89 chloride was administered intravenously at a dose of 148 MBq (4mCi). There was a transient, moderate, tolerable pain flare (Visual Analogue Scale pain score of 4) within the first week of treatment, which was relieved by oral opioid analgesics. He was pain-free thereafter (Visual Analogue Scale pain score of 0). Reversible bone marrow suppression was also observed a few weeks after the treatment.


Subject(s)
Humans , Male , Aged , Analgesics, Opioid , Radiopharmaceuticals , Strontium , Thyroid Gland , Bone Marrow , Quality of Life , Visual Analog Scale , Prostatic Neoplasms , Bone Neoplasms , Pain Management
SELECTION OF CITATIONS
SEARCH DETAIL